Multiple endocrine neoplasia type 1: Duodenopancreatic tumours

Journal of Internal Medicine

Volumn 253, Issue 6, 2003, Pages 590-598

  Doherty, Gerard M ^a,b   Thompson, N W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gastrinoma; Islet cell tumour; MEN1; Pancreas

Indexed keywords

SOMATOSTATIN RECEPTOR;

CANCER SCREENING; CONFERENCE PAPER; DUODENUM TUMOR; ENDOCRINE TUMOR; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; GASTRINOMA; GLUCAGONOMA; GRFOMA; HUMAN; INSULINOMA; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; PPOMA; PRIORITY JOURNAL; SCINTIGRAPHY; SOMATOSTATINOMA; VIPOMA;

AGED; CARCINOMA, ISLET CELL; DUODENAL NEOPLASMS; ENDOSONOGRAPHY; FEMALE; GASTRINOMA; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC HORMONES; PANCREATIC NEOPLASMS; POSTOPERATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038019505     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01163.x     Document Type: Conference Paper

References (33)

1. Larsson C, Skogseid B, Öberg K, Nakamura Y. Nordenskjôld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85-7.
2. Chandrasekharappa SC, Guru Sc. Manikam P et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-7.
3. Skogseid B, Doherty GM. Multiple endocrine neoplasia type 1: clinical and genetic features. Digestive & Liver Disease 1999. 31 (Suppl. 2): S131-4.
4. Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metabol. 2001; 86: 5658-71.
5. Skogseid BS, Rastad J, Oberg K. Multiple endocrine neoplasia type 1: Clinical features and screening. Endocrinol Metab Clin North Am 1994; 23: 1-18.
6. Vasen HF, Lamers CBH, Lips CJM. Screening for the multiple endocrine neoplasia syndrome type 1. Arch Intern Med 1989; 149: 2717-22.
7. Skogseid BS. Eriksson B, Lundqvist G et al. Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73: 281-7.
8. Skogseid BS. Oberg K, Benson L et al. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab 1987; 64: 1233-40.
9. Olson JA, DeBenedetti M. Wells SA, Doherty GM. Islet cell neoplasia in multiple endocrine neoplasia. type 1: Development of a provocative screening test. Surg Forum 1996; 47: 170-3.
10. Yim JH, Siegel BA. DeBenedetti MK, Norton JA. Lairmore TC, Doherty GM. Prospective study of the utility of somatostatin receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type I. Surgery 1998; 124: 1037-42.
11. Meko JB, Doherty GM, Siegel BA, Norton JA. Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors. Surgery 1996: 120: 975-84.
12. Gauger PG, Scheiman JM. Wamsteker E-J, Richards ML. Doherty GM, Thompson NW. An aggressive strategy of early anatomic screening and operative treatment of pancreatic endocrine tumors in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 2003, in press.
13. Thompson NW, Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN I syndrome. Henry Ford Hosp Med J 1992; 40: 195-8.
14. Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC, Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery 1993; 114: 1183-8.
15. Cherner JA. Sawyers JL. Benefit of resection of metastatic gastrinoma in multiple endocrine neoplasia type I. Gastroenterology 1992; 102: 1049-53.
16. Pipeleers-Marichal M, Somers G. Willems G etal. Gastrinomas in the duodenums of patients with multiple endocrine neoplasic type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990: 322: 723-7.
17. Pipeleers-Marichal M, Donow C, Heitz PU. Kloppel G. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. World J Surg, 1993; 17: 481-8.
18. Sheppard BC. Norton JA, Doppman JL, Maton PN. Gardner JD, Jensen RT. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery. 1989: 106: 1108-18.
19. Grama D, Skogseid B, Wilander E et al. Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg 1992; 16: 611-8.
20. Jadoul M. Koppeschaar HPF. Bax MA et al. Insulinomas in MEN1 patients: early detection and treatment of insulinomas in patients with the multiple endocrine neoplasia syndrome type-1. Neth J Med 1990; 37: 95-102.
21. Mignon M, Ruszniewski P, Podevin P et al. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg 1993; 17: 489-97.
22. O'Riordain DS, O'Brien T. VanHeerden JA. Service FJ, Grant CS. Surgical management of insulinoma associated with multiple endocrine neoplasia type 1.. World J Surg 1994: 18: 488-94.
23. Cohen MS, Picus D. Lairmore TC. Strasberg SM, Doherty GM, Norton JA. Prospective study of provocative angiograms to localize functional islet cell tumors of the pancreas. Surgery 1997; 122; 1091-101.
24. Doherty GM, Skogseid BM. Surgical Endocrinology, Philadelphia, PA: Lippincott, Williams and Wilkins, 2001.
25. Mutch MG, Frisella MM. DeBenedetti MK et al. Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery 1997; 122: 1012-20.
26. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA. Norton JA. Lethality of multiple endocrine neoplasia type 1. World J Surg 1998: 22: 581-6.
27. Shepherd JJ. The natural history of multiple endocrine neoplasia type 1.. Arch Surg 1991; 126: 935-52.
28. Wilkinson S, Teh BT, Davey KR, McArdle JP. Young M. Shepherd JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 1993: 128: 683-90.
29. Dean PG, van Heerden JA. Farley DR et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death? World J Surg 2000: 24: 1437-41.
30. Lowney JK. Frisella MM, Lairmore TC. Doherty GM. Islet cell tumor metastasis in multiple endocrine neoplasia type I: correlation with primary tumor size. Surgery 1998; 124: 1043-49.
31. Skogseid B, Oberg K, Eriksson B et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg 1996; 20: 872-7.
32. Lairmore TC, Chen VY, DeBenedetti MK. Gillanders WE, Norton JA. Doherty GM. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 2000: 231: 909-18.
33. Skogseid B, Grama D, Rastad J et al. Operative tumour yields obviates preoperative pancreatic tumor localization in multiple endocrine neoplasia type 1. J Intern Med 1995; 238: 281-8.